Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

FDA panel backs sleep pattern drug for blind

Vanda’s Hetlioz intended to improve circadian rhythms in people who cannot see

- PMLiVE

Sales down at Merck Serono on Rebif pressure

New MS drugs impact pharma company’s revenues

- PMLiVE

Lead not follow in branding

How to write a more competitive brand strategy

BMS appoints Giovanni Caforio as chief commercial officer

Also hands Charles Bancroft an expanded brief

Roche - Basel

Roche cuts $1bn deal on cancer therapy with Immatics

Licenses series of early-stage oncology immunotherapy programmes

- PMLiVE

FDA clears J&J’s breakthrough lymphoma therapy

Imbruvica approved to treat mantle cell lymphoma

- PMLiVE

New head for UK PR Council

PRCA appoints Lansons Communications’ CEO Tony Langham

- PMLiVE

Eveo lands in London

Eveo's UK presence to be led by Cheslea Goodman

- PMLiVE

ISPE looks to Boehringer for new VP of Europe

Thomas Zimmer was senior VP at German pharma company

- PMLiVE

Text messages studied as tool for cutting type 2 diabetes risk

Imperial College London teams up with Rapide

ABPI London offices

ABPI pledges greater payment transparency

UK pharma trade body updates Code of Practice

- PMLiVE

Sarepta slumps as FDA questions muscular dystrophy drug

US regulator casts doubt on biomarker for eteplirsen

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links